Literature DB >> 25725775

CT characteristics and pathological implications of early stage (T1N0M0) lung adenocarcinoma with pure ground-glass opacity.

Xin Jin1, Shao-hong Zhao, Jie Gao, Dian-jun Wang, Jian Wu, Chong-chong Wu, Rui-ping Chang, Hai-yue Ju.   

Abstract

OBJECTIVES: To analyze the CT characteristics and pathological classification of early lung adenocarcinoma (T1N0M0) with pure ground-glass opacity (pGGO).
METHODS: Ninety-four lesions with pGGO on CT in 88 patients with T1N0M0 lung adenocarcinoma were selected from January 2010 to December 2012. All lesions were confirmed by pathology. CT appearances were analyzed including lesion location, size, density, uniformity, shape, margin, tumour-lung interface, internal and surrounding malignant signs. Lesion size and density were compared using analysis of variance, lesion size also assessed using ROC curves. Gender of patients, lesion location and CT appearances were compared using χ²-test.
RESULTS: There were no significant differences in gender, lesion location and density with histological invasiveness (P > 0.05). The ROC curve showed that the possibility of invasive lesion was 88.73% when diameter of lesion was more than 10.5 mm. There was a significant difference between lesion uniformity and histological invasiveness (P = 0.01). There were significant differences in margin, tumour-lung interface, air bronchogram with histological invasiveness ( P = 0.02,P = 0.00,P = 0.048). The correlation index of lesion size and uniformity was r = 0.45 (P = 0.00).
CONCLUSIONS: The lesion size and uniformity, tumour-lung interface and the air bronchogram can help predict invasive extent of early stage lung adenocarcinoma with pGGO. KEY POINTS: • CT characteristics and pathological classification of pGGO lung adenocarcinoma smaller than 3 cm • The optimal cut-off value for discriminating preinvasive from invasive lesions was 10.5 mm • Uniformity was significant difference between histological subtypes and correlated with lesion size • Tumour margin, tumour-lung interface and air bronchogram showed different between histological types • No significant difference in gender, lesion location and density with histological subtypes.

Entities:  

Mesh:

Year:  2015        PMID: 25725775     DOI: 10.1007/s00330-015-3637-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

1.  Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.

Authors:  Feng Li; Shusuke Sone; Hiroyuki Abe; Heber Macmahon; Kunio Doi
Journal:  Radiology       Date:  2004-10-21       Impact factor: 11.105

2.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.

Authors:  Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

3.  Predictive CT findings of malignancy in ground-glass nodules on thin-section chest CT: the effects on radiologist performance.

Authors:  Hyun Ju Lee; Jin Mo Goo; Chang Hyun Lee; Chang Min Park; Kwang Gi Kim; Eun-Ah Park; Ho Yun Lee
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

4.  Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification.

Authors:  T Honda; T Kondo; S Murakami; H Saito; F Oshita; H Ito; M Tsuboi; H Nakayama; T Yokose; Y Kameda; T Isobe; K Yamada
Journal:  Clin Radiol       Date:  2012-11-10       Impact factor: 2.350

5.  Pulmonary malignant focal ground-glass opacity nodules and solid nodules of 3cm or less: comparison of multi-detector CT features.

Authors:  Li Fan; Shi-Yuan Liu; Qing-Chu Li; Hong Yu; Xiang-Sheng Xiao
Journal:  J Med Imaging Radiat Oncol       Date:  2011-06       Impact factor: 1.735

Review 6.  Overview and strategic management of subsolid pulmonary nodules.

Authors:  Myrna C B Godoy; David P Naidich
Journal:  J Thorac Imaging       Date:  2012-07       Impact factor: 3.000

7.  Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons.

Authors:  Ha Young Kim; Young Mog Shim; Kyung Soo Lee; Joungho Han; Chin A Yi; Yoon Kyung Kim
Journal:  Radiology       Date:  2007-10       Impact factor: 11.105

8.  Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications.

Authors:  Hyun-Ju Lim; Soomin Ahn; Kyung Soo Lee; Joungho Han; Young Mog Shim; Sookyoung Woo; Jae-Hun Kim; Miyeon Yie; Ho Yun Lee; Chin A Yi
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

9.  CT characteristics of resolving ground-glass opacities in a lung cancer screening programme.

Authors:  L Felix; G Serra-Tosio; S Lantuejoul; J F Timsit; D Moro-Sibilot; C Brambilla; G R Ferretti
Journal:  Eur J Radiol       Date:  2009-10-04       Impact factor: 3.528

Review 10.  Subsolid pulmonary nodules: imaging evaluation and strategic management.

Authors:  Myrna C B Godoy; Bradley Sabloff; David P Naidich
Journal:  Curr Opin Pulm Med       Date:  2012-07       Impact factor: 3.155

View more
  34 in total

1.  Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.

Authors:  Youngkyu Moon; Sook Whan Sung; Kyo Young Lee; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma.

Authors:  Youngkyu Moon; Sook Whan Sung; Kyo Young Lee; Sung Bo Sim; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Pure ground-glass nodules: are they really indolent?

Authors:  Julien G Cohen; Gilbert R Ferretti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

4.  Adenocarcinoma in pure ground glass nodules: histological evidence of invasion and open debate on optimal management.

Authors:  Gianluca Milanese; Nicola Sverzellati; Ugo Pastorino; Mario Silva
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

5.  Analysis of CT morphologic features and attenuation for differentiating among transient lesions, atypical adenomatous hyperplasia, adenocarcinoma in situ, minimally invasive and invasive adenocarcinoma presenting as pure ground-glass nodules.

Authors:  Lin Qi; Ke Xue; Cheng Li; Wenjie He; Dingbiao Mao; Li Xiao; Yanqing Hua; Ming Li
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

6.  Computer-Aided Diagnosis of Ground-Glass Opacity Nodules Using Open-Source Software for Quantifying Tumor Heterogeneity.

Authors:  Ming Li; Vivek Narayan; Ritu R Gill; Jyothi P Jagannathan; Maria F Barile; Feng Gao; Raphael Bueno; Jagadeesan Jayender
Journal:  AJR Am J Roentgenol       Date:  2017-10-18       Impact factor: 3.959

7.  CT and histopathologic characteristics of lung adenocarcinoma with pure ground-glass nodules 10 mm or less in diameter.

Authors:  Fang Wu; Shu-Ping Tian; Xin Jin; Rui Jing; Yue-Qing Yang; Mei Jin; Shao-Hong Zhao
Journal:  Eur Radiol       Date:  2017-04-06       Impact factor: 5.315

8.  Lung Adenocarcinoma: Predictive Value of KRAS Mutation Status in Assessing Local Recurrence in Patients Undergoing Image-guided Ablation.

Authors:  Etay Ziv; Joseph P Erinjeri; Hooman Yarmohammadi; F Edward Boas; Elena N Petre; Song Gao; Waleed Shady; Constantinos T Sofocleous; David R Jones; Charles M Rudin; Stephen B Solomon
Journal:  Radiology       Date:  2016-07-19       Impact factor: 11.105

9.  Analysis of pulmonary pure ground-glass nodule in enhanced dual energy CT imaging for predicting invasive adenocarcinoma: comparing with conventional thin-section CT imaging.

Authors:  Ying Zhang; Jian Tang; Jianrong Xu; Jiejun Cheng; Huawei Wu
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

10.  Spectral CT imaging parameters and Ki-67 labeling index in lung adenocarcinoma.

Authors:  Mailin Chen; Xiaoting Li; Yiyuan Wei; Liping Qi; Ying-Shi Sun
Journal:  Chin J Cancer Res       Date:  2020-02       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.